Related references
Note: Only part of the references are listed.Loss of fatty acid synthase inhibits the HER2-PI3K/Akt axis activity and malignant phenotype of Caco-2 cells
Nan Li et al.
LIPIDS IN HEALTH AND DISEASE (2013)
Fatty acid synthase expression associated with NAC1 is a potential therapeutic target in ovarian clear cell carcinomas
M. T. Rahman et al.
BRITISH JOURNAL OF CANCER (2012)
Fatty Acid Synthase Regulates Proliferation and Migration of Colorectal Cancer Cells Via HER2-PI3K/Akt Signaling Pathway
Nan Li et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2012)
Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells
Thomas W. Grunt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells
A. Vazquez-Martin et al.
CELL PROLIFERATION (2008)
Cohort Study of Fatty Acid Synthase Expression and Patient Survival in Colon Cancer
Shuji Ogino et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Javier A. Menendez et al.
NATURE REVIEWS CANCER (2007)
Energy metabolism of the cancer cell: example of mitochondria-rich endocrine tumors - Conference given during the annual reunion of the GTE in Angers - november 17th 2005
Y. Malthiery et al.
ANNALES D ENDOCRINOLOGIE (2006)
HER2/neu oncoprotein overexpression in epithelial ovarian cancer: Evaluation of its prevalence and prognostic significance - Clinical study
E Verri et al.
ONCOLOGY (2005)
Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas
Y Wang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Rates of topoisomerase II-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma
MS Mano et al.
GYNECOLOGIC ONCOLOGY (2004)
Overexpression of HER-2/neu is not a risk factor in ovarian clear cell adenocarcinorna
H Tanabe et al.
GYNECOLOGIC ONCOLOGY (2004)
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells
JA Menendez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
HER-2 overexpression is an independent marker of poor prognosis of advanced primary ovarian carcinoma: a multicenter study of the GINECO group
S Camilleri-Broet et al.
ANNALS OF ONCOLOGY (2004)
被撤回的出版物: The prognostic and predictive value of immunohistochemically detected HER-2/neu overexpression in 361 patients with ovarian cancer: a multicenter study (Retracted Article. See vol 96, pg 1021, 2005)
EK Riener et al.
GYNECOLOGIC ONCOLOGY (2004)
Distribution of HER-2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma - From the Danish MALOVA ovarian cancer study
EVS Hogdall et al.
CANCER (2003)
The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung
CJ Piyathilake et al.
HUMAN PATHOLOGY (2000)
Share Paper
